FDA Approved: GLYCEROL PHENYLBUTYRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental submission for glycerol phenylbutyrate, a nitrogen-scavenging therapy for urea cycle disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urea Cycle Disorders

Drugs mentioned

• Glycerol phenylbutyrate (glycerol phenylbutyrate)

Snippet

SUPPL AP for GLYCEROL PHENYLBUTYRATE (GLYCEROL PHENYLBUTYRATE)